Related Experiment Video

Updated: Aug 12, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

Spontaneous regression of cancer: new insights

B A Stoll1

  • 1Department of Oncology, St. Thomas' Hospital, London, UK.

Biotherapy (Dordrecht, Netherlands)
|January 1, 1992
PubMed

Insights

Suppressing oncogene expression and growth factors can lead to cancer regression or dormancy. Studying these changes in patients with dormant cancer may reveal new biological strategies for long-term cancer arrest.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Oncology

Background:

  • Oncogene suppression and altered growth factor signaling are implicated in spontaneous cancer regression and dormancy.
  • Loss of oncogenes essential for proliferation can induce cancer cell differentiation.
  • Natural and chemical agents can trigger these differentiation changes, with a focus on growth factors and immunological factors.

Purpose of the Study:

  • To explore biological methods for prolonging cancer arrest.
  • To investigate the role of oncogene suppression and growth factor modulation in cancer dormancy.
  • To identify potential biomarkers for predicting or maintaining cancer dormancy.

Main Methods:

  • Analyzing cytogenetic abnormalities in cancer patients.
  • Assessing alterations in oncogene expression.
  • Evaluating the immunocytological composition of tumors.
  • Correlating these factors with prolonged cancer dormancy.

Main Results:

  • Oncogene suppression and altered growth factor/receptor expression are linked to spontaneous cancer regression or dormancy.
  • Loss of critical oncogenes can result in cancer cell differentiation.
  • Natural factors, particularly growth factors and immunological components, play a role in triggering these processes.

Conclusions:

  • Understanding the mechanisms of oncogene suppression and growth factor modulation is crucial for cancer dormancy.
  • Investigating cytogenetic, oncogene expression, and immunocytological profiles in dormant cancer patients may yield new therapeutic strategies.
  • This research may inform the development of methods to achieve prolonged cancer arrest.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...